Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.

Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Resúmenes publicados
Búsqueda
Corea y enfermedad de Huntington Chorea & Huntington’s disease 237 artículos Viendo del 1 al 40 de 237 artículos
Pub MED

Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease.NUEVO

Yang W, Xie J, Qiang Q, Li L, Lin X, Ren Y, Ren W, Liu Q, Zhou G, Wei W, Saiyin H, Ma L.
Neurosci Bull. 2019 Dec;35(6):1024-1034. doi: 10.1007/s12264-019-00421-5. Epub 2019 Aug 20.
Pub MED

Discrete changes in the frequency and functions of autobiographical reminiscence in Huntington's disease.NUEVO

Carmichael AM, Irish M, Glikmann-Johnston Y, Stout JC.
Memory. 2019 Nov;27(10):1345-1351. doi: 10.1080/09658211.2019.1654519. Epub 2019 Aug 19.
Pub MED

Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease.NUEVO

Sjögren M, Soylu-Kucharz R, Dandunna U, Stan TL, Cavalera M, Sandelius Å, Zetterberg H, Björkqvist M.
Neurobiol Dis. 2019 Dec;132:104560. doi: 10.1016/j.nbd.2019.104560. Epub 2019 Aug 13.
Pub MED

Speech in prodromal and symptomatic Huntington's disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases.NUEVO

Chan JCS, Stout JC, Vogel AP.
Neurosci Biobehav Rev. 2019 Dec;107:450-460. doi: 10.1016/j.neubiorev.2019.08.009. Epub 2019 Aug 13. Review.
Pub MED

The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease.NUEVO

Wanker EE, Ast A, Schindler F, Trepte P, Schnoegl S.
J Neurochem. 2019 Nov;151(4):507-519. doi: 10.1111/jnc.14853. Epub 2019 Sep 15. Review.
Pub MED

Cytotoxicity models of Huntington's disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies.NUEVO

Calabrese EJ, Bhatia TN, Calabrese V, Dhawan G, Giordano J, Hanekamp YN, Kapoor R, Kozumbo WJ, Leak RK.
Pharmacol Res. 2019 Dec;150:104371. doi: 10.1016/j.phrs.2019.104371. Epub 2019 Aug 12. Review.
Pub MED

Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN).NUEVO

Hawton A, Green C, Goodwin E, Harrower T.
Eur J Health Econ. 2019 Dec;20(9):1335-1347. doi: 10.1007/s10198-019-01092-9. Epub 2019 Aug 13.
Pub MED

Validity of irritability in Huntington's disease: A scoping review.NUEVO

Simpson J, Dale M, Theed R, Gunn S, Zarotti N, Eccles FJR.
Cortex. 2019 Nov;120:353-374. doi: 10.1016/j.cortex.2019.06.012. Epub 2019 Jul 8. Review.
Pub MED

Antibody-based therapies for Huntington's disease: current status and future directions.NUEVO

Denis HL, David LS, Cicchetti F.
Neurobiol Dis. 2019 Dec;132:104569. doi: 10.1016/j.nbd.2019.104569. Epub 2019 Aug 6. Review.
Pub MED

Do BDNF and NT-4/5 exert synergistic or occlusive effects on corticostriatal transmission in a male mouse model of Huntington's disease?NUEVO

Torres-Cruz FM, Mendoza E, Vivar-Cortés IC, García-Sierra F, Hernández-Echeagaray E.
J Neurosci Res. 2019 Dec;97(12):1665-1677. doi: 10.1002/jnr.24507. Epub 2019 Aug 7.
Pub MED

Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.NUEVO

Smarr B, Cutler T, Loh DH, Kudo T, Kuljis D, Kriegsfeld L, Ghiani CA, Colwell CS.
J Neurosci Res. 2019 Dec;97(12):1606-1623. doi: 10.1002/jnr.24505. Epub 2019 Jul 29.
Pub MED

Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.NUEVO

Cepeda C, Oikonomou KD, Cummings D, Barry J, Yazon VW, Chen DT, Asai J, Williams CK, Vinters HV.
J Neurosci Res. 2019 Dec;97(12):1624-1635. doi: 10.1002/jnr.24503. Epub 2019 Jul 28. Review.
Pub MED

Dysfunctional striatal dopamine signaling in Huntington's disease.NUEVO

Koch ET, Raymond LA.
J Neurosci Res. 2019 Dec;97(12):1636-1654. doi: 10.1002/jnr.24495. Epub 2019 Jul 15. Review.
Pub MED

Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease.NUEVO

Tobore TO.
J Neurosci Res. 2019 Nov;97(11):1455-1468. doi: 10.1002/jnr.24492. Epub 2019 Jul 15. Review.
Pub MED

Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene.NUEVO

Franich NR, Hickey MA, Zhu C, Osborne GF, Ali N, Chu T, Bove NH, Lemesre V, Lerner RP, Zeitlin SO, Howland D, Neueder A, Landles C, Bates GP, Chesselet MF.
J Neurosci Res. 2019 Dec;97(12):1590-1605. doi: 10.1002/jnr.24493. Epub 2019 Jul 7.
Pub MED

Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington's disease.NUEVO

Matlahov I, van der Wel PC.
Exp Biol Med (Maywood). 2019 Dec;244(17):1584-1595. doi: 10.1177/1535370219856620. Epub 2019 Jun 15. No abstract available.
Pub MED

Visual Object Perception in Premanifest and Early Manifest Huntington's Disease.NUEVO

Coppen EM, Jacobs M, van der Zwaan KF, Middelkoop HAM, Roos RAC.
Arch Clin Neuropsychol. 2019 Nov 27;34(8):1320-1328. doi: 10.1093/arclin/acz002.
Pub MED

Motivational Impairment is Accompanied by Corticoaccumbal Dysfunction in the BACHD-Tg5 Rat Model of Huntington's Disease.NUEVO

Zlebnik NE, Gildish I, Sesia T, Fitoussi A, Cole EA, Carson BP, Cachope R, Cheer JF.
Cereb Cortex. 2019 Dec 17;29(11):4763-4774. doi: 10.1093/cercor/bhz009.
Pub MED

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.NUEVO

Sayed NH, Fathy N, Kortam MA, Rabie MA, Mohamed AF, Kamel AS.
Neurotherapeutics. 2019 Nov 14. doi: 10.1007/s13311-019-00805-5. [Epub ahead of print]
Pub MED

Discovery of a potent small molecule inhibiting Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein.NUEVO

Khan E, Mishra SK, Mishra R, Mishra A, Kumar A.
Sci Rep. 2019 Nov 14;9(1):16872. doi: 10.1038/s41598-019-53410-z.
Pub MED

Association Between Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease.NUEVO

Vuono R, Kouli A, Legault EM, Chagnon L, Allinson KS, La Spada A; REGISTRY Investigators of the European Huntington's Disease Network., Biunno I, Barker RA, Drouin-Ouellet J.
Mov Disord. 2019 Nov 14. doi: 10.1002/mds.27911. [Epub ahead of print]
Pub MED

HDQLIFE and Neuro-QoL Physical Function Measures: Responsiveness in Persons With Huntington's Disease.NUEVO

Carlozzi NE, Boileau NR, Chou KL, Ready RE, Cella D, McCormack MK, Miner JA, Dayalu P.
Mov Disord. 2019 Nov 14. doi: 10.1002/mds.27908. [Epub ahead of print]
Pub MED

Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington's Disease Monkey pluripotent stem cells.NUEVO

Goodnight AV, Kremsky I, Khampang S, Jung YH, Billingsley JM, Bosinger SE, Corces VG, Chan AWS.
Epigenetics Chromatin. 2019 Nov 13;12(1):67. doi: 10.1186/s13072-019-0313-6.
Pub MED

Exploration of a Co-Production Approach to Developing a Walking Group with People with Huntington's Disease.NUEVO

Jones U, Hamana K, Vougioukalou S, Jones M, Busse M.
Med One. 2019;4(5):e190022. doi: 10.20900/mo.20190022. Epub 2019 Oct 31.
Pub MED

Deterioration of neuroregenerative plasticity in association with testicular atrophy and dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis in Huntington's disease: A putative role of the huntingtin gene in steroidogenesis.NUEVO

Selvaraj K, Manickam N, Kumaran E, Thangadurai K, Elumalai G, Sekar A, Radhakrishnan RK, Kandasamy M.
J Steroid Biochem Mol Biol. 2019 Nov 9;197:105526. doi: 10.1016/j.jsbmb.2019.105526. [Epub ahead of print] Review.
Pub MED

Awareness of Chorea in Huntington's Disease.NUEVO

Hergert DC, Sanchez-Ramos J, Cimino CR.
J Huntingtons Dis. 2019 Nov 5. doi: 10.3233/JHD-190381. [Epub ahead of print]
Pub MED

Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington's disease patients.NUEVO

Ramirez-Garcia G, Galvez V, Diaz R, Bayliss L, Fernandez-Ruiz J, Campos-Romo A.
Eur J Neurosci. 2019 Nov 9. doi: 10.1111/ejn.14617. [Epub ahead of print]
Pub MED

Longitudinal study revealing motor, cognitive and behavioral decline in a transgenic minipig model of Huntington's disease.NUEVO

Baxa M, Levinska B, Skrivankova M, Pokorny M, Juhasova J, Klima J, Klempir J, Motlı K J, Juhas S, Ellederova Z.
Dis Model Mech. 2019 Dec 12;13(2). pii: dmm041293. doi: 10.1242/dmm.041293.
Pub MED

The effect of impulsivity and inhibitory control deficits in the saccadic behavior of premanifest Huntington's disease individuals.NUEVO

Júlio F, Caetano G, Januário C, Castelo-Branco M.
Orphanet J Rare Dis. 2019 Nov 8;14(1):246. doi: 10.1186/s13023-019-1218-y.
Pub MED

Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice.NUEVO

Kedaigle AJ, Reidling JC, Lim RG, Adam M, Wu J, Wassie B, Stocksdale JT, Casale MS, Fraenkel E, Thompson LM.
Hum Mol Genet. 2019 Nov 7. pii: ddz264. doi: 10.1093/hmg/ddz264. [Epub ahead of print]
Pub MED

Genetic deletion of S6k1 does not rescue the phenotypic deficits observed in the R6/2 mouse model of Huntington's disease.NUEVO

Irvine EE, Katsouri L, Plattner F, Al-Qassab H, Al-Nackkash R, Bates GP, Withers DJ.
Sci Rep. 2019 Nov 6;9(1):16133. doi: 10.1038/s41598-019-52391-3.
Pub MED

Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.NUEVO

Estrada-Sánchez AM, Blake CL, Barton SJ, Howe AG, Rebec GV.
J Neurophysiol. 2019 Dec 1;122(6):2621-2629. doi: 10.1152/jn.00777.2018. Epub 2019 Nov 6.
Pub MED

Chorea-like symptoms and high blood concentration of ceftriaxone in a patient undergoing hemodialysis: A case report.NUEVO

Yokoyama Y, Hosokawa N, Kudo T, Goda H, Ito K, Suzuki M, Funakoshi R.
J Infect Chemother. 2019 Oct 31. pii: S1341-321X(19)30305-8. doi: 10.1016/j.jiac.2019.10.005. [Epub ahead of print]
Pub MED

Implicit learning impairment identified via predictive saccades in Huntington's disease correlates with extended cortico-striatal atrophy.NUEVO

Vaca-Palomares I, Brien DC, Coe BC, Ochoa-Morales A, Martínez-Ruano L, Munoz DP, Fernandez-Ruiz J.
Cortex. 2019 Dec;121:89-103. doi: 10.1016/j.cortex.2019.06.013. Epub 2019 Jul 12.
Pub MED

Huntington's disease associated resistance to Mn neurotoxicity is neurodevelopmental stage and neuronal lineage dependent.NUEVO

Joshi P, Bodnya C, Ilieva I, Neely MD, Aschner M, Bowman AB.
Neurotoxicology. 2019 Dec;75:148-157. doi: 10.1016/j.neuro.2019.09.007. Epub 2019 Sep 20.
Pub MED

Multimodal characterization of the visual network in Huntington's disease gene carriers.NUEVO

Gregory S, Odish OFF, Mayer I, Mills J, Johnson EB, Scahill RI, Rothwell J, Rees G, Long JD, Tabrizi SJ, Roos RAC, Orth M.
Clin Neurophysiol. 2019 Nov;130(11):2053-2059. doi: 10.1016/j.clinph.2019.08.018. Epub 2019 Aug 28.
Pub MED

Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington's disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/β-catenin signalling pathways.NUEVO

Elbaz EM, Helmy HS, El-Sahar AE, Saad MA, Sayed RH.
Neurochem Int. 2019 Dec;131:104548. doi: 10.1016/j.neuint.2019.104548. Epub 2019 Sep 17.
Pub MED

Sex-dependent impaired locomotion and motor coordination in the HdhQ200/200 mouse model of Huntington's Disease.NUEVO

Cao JK, Viray K, Zweifel L, Stella N.
Neurobiol Dis. 2019 Dec;132:104607. doi: 10.1016/j.nbd.2019.104607. Epub 2019 Sep 6.
Pub MED

Corticostriatal synaptic plasticity alterations in the R6/1 transgenic mouse model of Huntington's disease.NUEVO

Ghiglieri V, Campanelli F, Marino G, Natale G, Picconi B, Calabresi P.
J Neurosci Res. 2019 Dec;97(12):1655-1664. doi: 10.1002/jnr.24521. Epub 2019 Sep 9.
Pub MED

Progressive cardiac arrhythmias and ECG abnormalities in the Huntington's disease BACHD mouse model.NUEVO

Zhu Y, Shamblin I, Rodriquez E, Salzer GE, Araysi L, Margolies KA, Halade G, Litovsky SH, Pogwizd S, Gray M, Huke S.
Hum Mol Genet. 2019 Dec 9. pii: ddz295. doi: 10.1093/hmg/ddz295. [Epub ahead of print]
Viendo del 1 al 40 de 237 artículos
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy